title: Serum level of interleukin-33 and soluble ST2 and their association with disease activity in patients with Behcet's disease.
abstract: Interleukin (IL)-33 is an important mediator of innate immunity. Behcet's disease (BD) is an autoinflammatory disorder characterized by hyperactivity of the innate immune response. We measured serum levels of IL-33 and its receptor soluble ST2 (sST2) in patients with BD to investigate their association with disease activity. Serum levels of both IL-33 and sST2 were higher in patients with BD compared with those in normal controls (IL-33: 594.48±175.04 pg/mL in BD and 224.23±56.64 pg/mL in normal controls [P=0.048], sST2: 99.01±15.92 pg/mL in BD and 23.56±3.25 pg/mL in normal controls [P<0.001]). IL-33 and sST2 expression in skin tissue, as shown by immunohistochemistry, was higher in patients with BD compared with that in the normal controls. Serum sST2 level correlated significantly with the BD currently active form (BDCAF), Iranian BD dynamic activity measure (IBDDAM), erythrocyte sedimentation rate and C-reactive protein. Multiple linear regression showed that serum sST2 was an independent factor associated with IBBDAM (regression coefficient, 0.374; P=0.004), and BDCAF (regression coefficient, 0.236; P=0.047). These results demonstrate that IL-33 and sST2 are highly expressed in patients with BD and that serum sST2 is an independent factor associated with IBDDAM and BDCAF, suggesting a potential role for sST2 as a surrogate marker of disease activity in patients with BD.
authors: Division of Rheumatology, Department of Internal Medicine, School of Medicine, The Catholic University of Korea, Seoul, Korea.
authors: Dae-Jun
authors: DJ
authors: Kim
authors: Seung-Ye
authors: SY
authors: Baek
authors: Mi-Kyung
authors: MK
authors: Park
authors: Kyung-Su
authors: KS
authors: Park
authors: Jae Ho
authors: JH
authors: Lee
authors: Sung-Hwan
authors: SH
authors: Park
authors: Ho-Youn
authors: HY
authors: Kim
authors: Seung-Ki
authors: SK
authors: Kwok
mesh_terms: D000328:Adult; D001528:Behcet Syndrome / Q000097:blood / Q000473:pathology*; D001799:Blood Sedimentation; D002097:C-Reactive Protein / Q000032:analysis; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D000072179:Interleukin-1 Receptor-Like 1 Protein; D000067596:Interleukin-33; D007378:Interleukins / Q000097:blood* / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D011956:Receptors, Cell Surface / Q000097:blood* / Q000378:metabolism; D012720:Severity of Illness Index; D012867:Skin / Q000378:metabolism / Q000473:pathology
chemical_list: C079241:IL1RL1 protein, human; C506536:IL33 protein, human; D000072179:Interleukin-1 Receptor-Like 1 Protein; D000067596:Interleukin-33; D007378:Interleukins; D011956:Receptors, Cell Surface; D002097:C-Reactive Protein
keywords: Behcet Syndrome; Interleukin-33; soluble ST2
references: Ann Rheum Dis. 2013 Feb;72(2):258-64
references: 22872024
references: Rheumatology (Oxford). 2010 Mar;49(3):520-7
references: 20026564
references: Allergol Int. 2010 Jun;59(2):143-60
references: 20414050
references: Cardiovasc Res. 2010 Sep 1;87(4):769-77
references: 20363761
references: J Korean Med Sci. 2011 Sep;26(9):1132-9
references: 21935266
references: PLoS One. 2008 Oct 06;3(10):e3331
references: 18836528
references: Proc Natl Acad Sci U S A. 2007 Jan 2;104(1):282-7
references: 17185418
references: Int J Mol Med. 2012 Apr;29(4):530-40
references: 22246057
references: Clin Exp Med. 2011 Jun;11(2):75-80
references: 20963466
references: Immunity. 2005 Nov;23(5):479-90
references: 16286016
references: Mod Rheumatol. 2009;19(5):536-41
references: 19590934
references: Rheumatology (Oxford). 1999 Aug;38(8):728-33
references: 10501420
references: J Rheumatol. 1996 Feb;23(2):321-2
references: 8882039
references: Biochem Biophys Res Commun. 2001 Jun 29;284(5):1104-8
references: 11414697
references: Biochem Biophys Res Commun. 2002 Nov 22;299(1):18-24
references: 12435383
references: EMBO J. 1994 Mar 1;13(5):1176-88
references: 8131748
references: Biochem Biophys Res Commun. 2006 Dec 29;351(4):940-6
references: 17097607
references: Clin Rheumatol. 2011 Dec;30(12):1583-8
references: 21968692
references: Arch Dermatol Res. 2013 Mar;305(2):173-7
references: 22836779
references: Proc Natl Acad Sci U S A. 2010 Oct 26;107(43):18581-6
references: 20937871
references: Mod Rheumatol. 2012 Feb;22(1):89-93
references: 21674220
references: J Immunol. 2004 Jul 1;173(1):145-50
references: 15210768
references: J Rheumatol. 2010 Oct;37(10):2006-13
references: 20682660
references: Ann Rheum Dis. 2010 Sep;69(9):1697-703
references: 20472598